Articles related to ANTITHROMBOTIC THERAPY

In a comprehensive Bayesian network meta-analysis, 1 month of DAPT followed by potent P2Y12 inhibitor monotherapy was associated with a significant reduction in major bleeding compared to the conventional 12 months of DAPT, without an increase in MACCE.

Lemierre’s syndrome, a rare complication of oropharyngeal infections, can lead to severe neurological manifestations such as cavernous sinus thrombosis and cranial nerve palsies.

Blood thinners interact with various medications and supplements, potentially increasing bleeding risk or reducing efficacy. Physicians should be aware of these interactions and educate patients on the importance of consulting healthcare professionals before taking new products.

In patients with both cirrhosis and atrial fibrillation, apixaban initiation was associated with lower rates of major bleeding compared to rivaroxaban or warfarin, without compromising thromboembolic protection.

This article discusses the largest malpractice verdict awarded to an individual over 70 in Illinois, emphasizing the importance of rigorous INR monitoring in anticoagulated patients to avoid severe complications.

The study found that andexanet alfa significantly improves hemostatic efficacy in patients with intracerebral hemorrhage on factor Xa inhibitors but increases the risk of thrombotic events. These findings highlight the need for careful patient selection and monitoring when considering andexanet alfa in clinical practice.